Pre-treatment inflammatory biomarkers predict early treatment response and favorable survival in patients with metastatic colorectal cancer who underwent first line cetuximab plus chemotherapy

OBJECTIVE: This study was to determine whether peripheral blood biomarkers including neutrophil‑lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and systemic immune inflammation index (SII) could predict early response to cetuximab; moreover, the prognostic ability of those biomarkers on pro...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Manag Res
Päätekijät: Jiang, Jinling, Ma, Tao, Xi, Wenqi, Yang, Chen, Wu, Junwei, Zhou, Chenfei, Wang, Nan, Zhu, Zhenggang, Zhang, Jun
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove 2019
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6767765/
https://ncbi.nlm.nih.gov/pubmed/31576170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S211089
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia